Skip to main content

Advertisement

Log in

Dietary manipulation of serotonergic and dopaminergic function in C57BL/6J mice with amino acid depletion mixtures

  • Neurology and Preclinical Neurological Studies - Original Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

Amino acid (AA) depletion techniques have been used to decrease serotonin (5-HT) and/or dopamine (DA) synthesis after administration of a tryptophan (acute tryptophan depletion, ATD) or phenylalanine/tyrosine-free (phenylalanine–tyrosine depletion, PTD) AA formula and are useful as neurochemical challenge procedures to study the impact of DA and 5-HT in patients with neuropsychiatric disorders. We recently demonstrated that the refined Moja-De ATD paradigm decreases brain 5-HT synthesis in humans and mice and lowers brain 5-HT turnover. In the present study we validated the neurochemical effects of three developed AA formulas on brain 5-HT and DA function in mice. To distinguish the direct and indirect effects of such mixtures on 5-HT and DA and to determine whether additive depletion of both could be obtained simultaneously, we compared the effects of ATD for 5-HT, PTD for DA, and a combined monoamine depletion mixture (CMD) compared to a control condition consisting of a balanced amino acid mixture. Food-deprived male C57BL/6J mice were gavaged with AA mixtures. Serum and brain samples were collected and analyzed for determination of tryptophan (Trp), tyrosine (Tyr), 5-HT, 5-HIAA, DA, DOPAC and HVA levels. ATD was the most effective at decreasing Trp, 5-HT and 5-HIAA. In contrast, PTD reduced Tyr globally but HVA only in certain brain regions. Although CMD affected both 5-HT and DA synthesis, it was less effective when compared with ATD or PTD alone. The present results demonstrate that two newly developed PTD and CMD formulas differentially impact brain 5-HT and DA synthesis relative to 5-HT-specific ATD Moja-De. Different effects on 5-HT and DA function by these mixtures suggest that the exact composition may be a critical determinant for effectiveness with respect to the administered challenge procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Abbott NJ, Rönnbäck L, Hansson E (2006) Astrocyte–endothelial interactions at the blood–brain barrier. Nat Rev Neurosci 7:41–53. doi:10.1038/nrn1824

    Article  CAS  PubMed  Google Scholar 

  • Badawy AA, Dougherty DM, Richard DM (2010a) Specificity of the acute tryptophan and tyrosine plus phenylalanine depletion and loading tests I. Review of biochemical aspects and poor specificity of current amino acid formulations. Int J Tryptophan Res 2010:23–34

    Article  PubMed  Google Scholar 

  • Badawy AA, Dougherty DM, Richard DM (2010b) Specificity of the acute tryptophan and tyrosine plus phenylalanine depletion and loading tests part II: normalisation of the tryptophan and the tyrosine plus phenylalanine to competing amino acid ratios in a new control formulation. Int J Tryptophan Res 3:35–47

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bell C (2001) Tryptophan depletion and its implications for psychiatry. Br J Psychiatry 178:399–405. doi:10.1192/bjp.178.5.399

    Article  CAS  PubMed  Google Scholar 

  • Biggio G, Fadda F, Fanni P et al (1974) Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free diet. Life Sci 14:1321–1329

    Article  CAS  PubMed  Google Scholar 

  • Biggio G, Porceddu ML, Gessa GL (1976) Decrease of homovanillic, dihydroxyphenylacetic acid and cyclic-adenosine-3′,5′-monophosphate content in the rat caudate nucleus induced by the acute administration of an aminoacid mixture lacking tyrosine and phenylalanine. J Neurochem 26:1253–1255

    Article  CAS  PubMed  Google Scholar 

  • Biskup CS, Sánchez CL, Arrant A et al (2012) Effects of acute tryptophan depletion on brain serotonin function and concentrations of dopamine and norepinephrine in C57BL/6J and BALB/cJ mice. PLoS One 7:e35916. doi:10.1371/journal.pone.0035916

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bongiovanni R, Newbould E, Jaskiw GE (2008) Tyrosine depletion lowers dopamine synthesis and desipramine-induced prefrontal cortex catecholamine levels. Brain Res 1190:39–48. doi:10.1016/j.brainres.2007.10.079

    Article  CAS  PubMed  Google Scholar 

  • Bongiovanni R, Kyser AN, Jaskiw GE (2012) Tyrosine depletion lowers in vivo DOPA synthesis in ventral hippocampus. Eur J Pharmacol 696:70–76. doi:10.1016/j.ejphar.2012.09.014

    Article  CAS  PubMed  Google Scholar 

  • Brand T, Anderson GM (2011) The measurement of platelet-poor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis. Clin Chem 57:1376–1386. doi:10.1373/clinchem.2011.163824

    Article  CAS  PubMed  Google Scholar 

  • Bröer S (2008) Amino acid transport across mammalian intestinal and renal epithelia. Physiol Rev 88:249–286. doi:10.1152/physrev.00018.2006

    Article  PubMed  Google Scholar 

  • Carlsson A, Lindqvist M (1978) Dependence of 5-HT and catecholamine synthesis on concentrations of precursor amino-acids in rat brain. Naunyn-Schmiedeberg’s Arch Pharmacol 303:157–164

    Article  CAS  Google Scholar 

  • Carpenter LL, Anderson GM, Pelton GH et al (1998) Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 19:26–35. doi:10.1016/S0893-133X(97)00198-X

    Article  CAS  PubMed  Google Scholar 

  • Christensen HN (1990) Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 70:43–77

    CAS  PubMed  Google Scholar 

  • Del Amo EM, Urtti A, Yliperttula M (2008) Pharmacokinetic role of l-type amino acid transporters LAT1 and LAT2. Eur J Pharm Sci Off J Eur Fed Pharm Sci 35:161–174. doi:10.1016/j.ejps.2008.06.015

    Google Scholar 

  • Delgado PL (2006) Monoamine depletion studies: implications for antidepressant discontinuation syndrome. J Clin Psychiatry 67:22–26

    CAS  PubMed  Google Scholar 

  • Dingerkus VLS, Gaber TJ, Helmbold K et al (2012) Acute tryptophan depletion in accordance with body weight: influx of amino acids across the blood–brain barrier. J Neural Transm 119:1037–1045. doi:10.1007/s00702-012-0793-z

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • During MJ, Acworth IN, Wurtman RJ (1988) Phenylalanine administration influences dopamine release in the rat’s corpus striatum. Neurosci Lett 93:91–95

    Article  CAS  PubMed  Google Scholar 

  • Eisenhofer G, Kopin IJ, Goldstein DS (2004) Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56:331–349. doi:10.1124/pr.56.3.1.mitters

    Article  CAS  PubMed  Google Scholar 

  • Elhwuegi AS (2004) Central monoamines and their role in major depression. Prog Neuro-psychopharmacol Biol Psychiatry Psychopharmacol Biol Psychiatry 28:435–451. doi:10.1016/j.pnpbp.2003.11.018

    Article  CAS  Google Scholar 

  • Fernstrom JD (1990) Aromatic amino acids and monoamine synthesis in the central nervous system: influence of the diet. J Nutr Biochem 1:508–517

    Article  CAS  PubMed  Google Scholar 

  • Fernstrom JD (2012) Large neutral amino acids: dietary effects on brain neurochemistry and function. Amino Acids. doi:10.1007/s00726-012-1330-y

    PubMed  Google Scholar 

  • Fernstrom JD, Fernstrom MH (2007) Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J Nutr 137:1539S–1547S (discussion 1548S)

    CAS  PubMed  Google Scholar 

  • Gijsman HJ, Scarnà A, Harmer CJ et al (2002) A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function. Psychopharmacology 160:192–197. doi:10.1007/s00213-001-0970-5

    Article  CAS  PubMed  Google Scholar 

  • Harmer CJ, McTavish SFB, Clark L et al (2001) Tyrosine depletion attenuates dopamine function in healthy volunteers. Psychopharmacology 154:105–111. doi:10.1007/s002130000613

    Article  CAS  PubMed  Google Scholar 

  • Hawkins RA, Kane RLO, Simpson IA, Vin JR (2006) Branched-chain amino acids: metabolism, physiological function, and application structure of the blood–brain barrier and its role in the transport of amino acids. J Nutr 136:218S–226S

    CAS  PubMed  Google Scholar 

  • Jakeman PM (1998) Amino acid metabolism, branched-chain amino acid feeding and brain monoamine function. Proc Nutr Soc 57:35–41

    Article  CAS  PubMed  Google Scholar 

  • Jedlitschky G, Greinacher A, Kroemer HK (2012) Transporters in human platelets: physiologic function and impact for pharmacotherapy. Blood 119:3394–3402. doi:10.1182/blood-2011-09-336933

    Article  CAS  PubMed  Google Scholar 

  • Kötting WF, Bubenzer S, Helmbold K et al (2013) Effects of tryptophan depletion on reactive aggression and aggressive decision-making in young people with ADHD. Acta Psychiatr Scand 128:114–123. doi:10.1111/acps.12001

    Article  PubMed  Google Scholar 

  • Lee M, Jayathilake K, Dai J, Meltzer HY (2011) Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: relationship to plasma cortisol concentration. Psychiatry Res 185:328–333. doi:10.1016/j.psychres.2010.07.013

    Article  CAS  PubMed  Google Scholar 

  • McTavish SF, Cowen PJ, Sharp T (1999) Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology 141:182–188

    Article  CAS  PubMed  Google Scholar 

  • Meier C, Ristic Z, Klauser S, Verrey F (2002) Activation of system l heterodimeric amino acid exchangers by intracellular substrates. EMBO J 21:580–589

    Article  CAS  PubMed  Google Scholar 

  • Moja EA, Stoff DM, Gessa GL et al (1988) Decrease in plasma tryptophan after tryptophan-free amino acid mixtures in man. Life Sci 42:1551–1556

    Article  CAS  PubMed  Google Scholar 

  • Moore P, Landolt HP, Seifritz E et al (2000) Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology 23:601–622. doi:10.1016/S0893-133X(00)00161-5

    Article  CAS  PubMed  Google Scholar 

  • Nagatsu T, Levitt M, Udenfriend S (1964) Tyrosine hydroxylase: the initial step in norepinephrine biosynthesis. J Biol Chem 239:2910–2917

    CAS  PubMed  Google Scholar 

  • Oldendorf WH, Szabo J (1976) Amino barrier acid assignment to one of three blood–brain amino acid carriers. Am J Physiol 230:94–98

    CAS  PubMed  Google Scholar 

  • Palmour RM, Ervin FR, Baker GB, Young SN (1998) An amino acid mixture deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine metabolites and alcohol consumption in vervet monkeys. Psychopharmacology 136:1–7

    Article  CAS  PubMed  Google Scholar 

  • Pardridge WM (1998) Blood–brain barrier carrier-mediated transport and brain metabolism of amino acids. Neurochem Res 23:635–644

    Article  CAS  PubMed  Google Scholar 

  • Porter RJ, Mulder RT, Joyce PR, Luty SE (2005) Tryptophan and tyrosine availability and response to antidepressant treatment in major depression. J Affect Disord 86:129–134. doi:10.1016/j.jad.2004.11.006

    Article  CAS  PubMed  Google Scholar 

  • Richard DM, Dawes MA, Mathias CW et al (2009) l-tryptophan: basic metabolic functions, behavioral research and therapeutic indications. Int J Tryptophan Res IJTR 2:45–60

    CAS  Google Scholar 

  • Scarnà A, Gijsman HJ, Harmer CJ et al (2002) Effect of branch chain amino acids supplemented with tryptophan on tyrosine availability and plasma prolactin. Psychopharmacology 159:222–223. doi:10.1007/s00213-001-0963-4

    Article  PubMed  Google Scholar 

  • Van Donkelaar EL, Blokland A, Lieben CKJ et al (2010) Acute tryptophan depletion in C57BL/6 mice does not induce central serotonin reduction or affective behavioural changes. Neurochem Int 56:21–34. doi:10.1016/j.neuint.2009.08.010

    Article  PubMed  Google Scholar 

  • Verrey F, Closs EI, Wagner CA et al (2004) CATs and HATs: the SLC7 family of amino acid transporters. Pflügers Arch Eur J Physiol 447:532–542. doi:10.1007/s00424-003-1086-z

    Article  CAS  Google Scholar 

  • Wurtman RJ, Fernstrom JD (1976) Control of brain neurotransmitter synthesis by precursor availability and nutritional state. Biochem Pharmacol 25:1691–1696

    Article  CAS  PubMed  Google Scholar 

  • Wurtman RJ, Larin F, Mostafapour S et al (1974) Brain catechol synthesis: control by brain tyrosine concentration. Science 185:183–184

    Article  CAS  PubMed  Google Scholar 

  • Young SN, Ervin FR, Pihl RO, Finn P (1989) Biochemical aspects of tryptophan depletion in primates. Psychopharmacology 98:508–511

    Article  CAS  PubMed  Google Scholar 

  • Zepf FD, Stadler C, Demisch L et al (2008) Serotonergic functioning and trait-impulsivity in influence of rapid tryptophan depletion. Hum Psychopharmacol 23:43–51. doi:10.1002/hup

    Article  CAS  PubMed  Google Scholar 

  • Zepf FD, Holtmann M, Stadler C, Wockel L, Poustka F (2009) Reduced serotonergic functioning changes heart rate in ADHD. J Neural Transm 116(1):105–108. doi:10.1007/s00702-008-0146-0

    Google Scholar 

  • Zhang X, Beaulieu J-M, Sotnikova TD et al (2004) Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305:217. doi:10.1126/science.1097540

    Article  CAS  PubMed  Google Scholar 

  • Zimmermann M, Grabemann M, Mette C et al (2012) The effects of acute tryptophan depletion on reactive aggression in adults with attention-deficit/hyperactivity disorder (ADHD) and healthy controls. PLoS One 7:e32023. doi:10.1371/journal.pone.0032023

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This study received funding from the Bundesministerium für Wirtschaft und Technologie (BMWi).

Conflict of interest

FDZ was the recipient of an unrestricted award donated by the American Psychiatric Association (APA), the American Psychiatric Institute for Research and Education (APIRE) and AstraZeneca (Young Minds in Psychiatry Award). He has also received research support from the German Federal Ministry for Economics and Technology, the German Society for Social Pediatrics and Adolescent Medicine, the Paul and Ursula Klein Foundation, the Dr. August Scheidel Foundation, the IZKF fund of the University Hospital of RWTH Aachen University, and a travel stipend donated by the GlaxoSmithKline Foundation. He is the recipient of an unrestricted educational grant, travel support and speaker honoraria by Shire Pharmaceuticals, Germany. In addition, he has received support from the Raine Foundation for Medical Research (Raine Visiting Professorship), and editorial fees from Co-Action Publishing (Sweden). All authors report no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cristina L. Sánchez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sánchez, C.L., Van Swearingen, A.E.D., Arrant, A.E. et al. Dietary manipulation of serotonergic and dopaminergic function in C57BL/6J mice with amino acid depletion mixtures. J Neural Transm 121, 153–162 (2014). https://doi.org/10.1007/s00702-013-1083-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-013-1083-0

Keywords

Navigation